Epigenetics Diagnostic Report 2019-2029

エピジェネティクス診断の世界市場2019-2029

◆タイトル:Epigenetics Diagnostic Report 2019-2029
◆商品コード:VGN910353
◆調査・発行会社:visiongain
◆発行日:2019年6月21日
◆ページ数:166
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle UserGBP3,499 ⇒換算¥468,866見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算¥522,466見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算¥669,866見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"エピジェネティクス診断の世界市場2019-2029"について調査・分析し、エグゼクティブサマリーなどの情報をお届けいたします。

Market Definition: • Epigenetics is referred to all molecular pathways modulating the expression of a genotype into a particular phenotype. Epigenetics consistently indicates changes that affect gene activity and expression, but it can also be used to illustrate any heritable phenotypic change.
• It is mainly a study of change in the gene expression without any change in gene sequence. Some of the examples consists of activating changes namely histone acetylation and DNA demethylation, repressive changes like DNA methylation and histone modifications influenced by noncoding RNAs, such as microRNA and long noncoding RNA.
Market Overview and Trends
• There are various epigenetic drugs developed and in clinical trials for aiming at histone deacetylation and DNA methylation enzymes.
• The factor which is predicted to further drive the expansion is the organizations, for example, the National Cancer Institute (NCI), the International Human Epigenome Consortium (IHEC) and the National Institute of Health (NIH) which encourage funding and support to R&D and product development exercises applicable to the field of epigenetics.
• Epigenetics research is paying particular attention to the discovery of treatment options for various types of tumours. The International Cancer Genome Consortium (ICGC) is focusing on acquiring the epigenomic changes, transcriptomic changes and genomic description in different types of tumours.
• With an objective to distinguish all the human genome sequence functional elements the Encyclopaedia of DNA Elements (ENCODE) project was launched by the U.S. National Human Genome Research Institute.
Market Dynamics:
Factors Influencing the Market Growth:
• Increasing frequency of cancer and other chronic diseases and growing geriatric population are some of the key factors predicted to drive the market.
• The factors driving the growth of this market is advancements in screening tools, rising incidence of cancer and huge amounts invested in research and development activities.
• The demand for epigenetic diagnosis and drugs is expected to increase due to the increase in ageing population and rising incidence of oncology and non- oncology disorders.
• Some of the factors contributing to fuelling the growth of the global epigenetics market are the increasing number of retail clinics, companion diagnostics and development of entire genome technology.
• The market is also driven by the increase in research and developmental activities which helps in expanding facilities in various fields such as clinical and pharmaceutical research.
Factors Restraining the Market Growth:
• The growth of epigenetic market is likely to be hampered by the lack of funds from the government and high cost of the procedures and consumers do not wish to invest in such expensive products, especially research groups with limited budgets and funding.
Market Segmentation 2019-2029:
The Epigenetics Diagnostic market is segmented on the product, technology, application and region.
1. Epigenetics Diagnostic, by Product
a) Reagents
b) Kits
– ChIP Sequencing Kit
– Whole Genomic Amplification Kit
– Bisulfite Conversion Kit
– RNA Sequencing Kit
– Others
c) Instruments
d) Enzymes
e) Services
2. Epigenetics Diagnostic, by Technology
a) DNA Methylation
– Reagents
– Kits
– Instruments
– Enzymes
– Services
b) Histone Methylation
– Reagents
– Kits
-Instruments
– Enzymes
– Services
c) Histone Acetylation
– Reagents
– Kits
– Instruments
– Enzymes
– Services
d) Large non-coding RNA
– Reagents
– Kits
– Instruments
-Enzymes
– Services
e) MicroRNA Modification
– Reagents
– Kits
– Instruments
– Enzymes
– Services
f) Chromatin structures
– Reagents
– Kits
– Instruments
– Enzymes
– Services
3. Epigenetics Diagnostic, by Application
a) Oncology
– Solid Tumours
– Liquid Tumours
b) Non-oncology
– Inflammatory Diseases
– Metabolic Diseases
– Infectious Diseases
– Cardiovascular Diseases
– Others
4. Epigenetics Diagnostic, by Region
a) North America
– US
– Canada
b) Europe
– Germany
– UK
– France
– Rest of Europe
c) Asia Pacific
– Japan
– China
– India
– Rest of Asia Pacific
d) Rest of the World (RoW)
Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Global Biodefense market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
Major Market Players:
Celgene Corporation, CellCentric Ltd, Chroma Therapeutics Ltd, Covaris Inc, DIAGENODE, INC., Ribimed Biotechnologies, Epigenomics AG, Epitherapeutics, Epizyme, Karus Therapeutics, Merck Millipore, Novartis International AG, Oncolys Biopharma Inc, OncoMethylome Sciences, Qiagen, Sigma-Aldrich Corporation, Syndax Pharmaceuticals and ZYMO RESEARCH CORPORATION (ZYMO).

【レポートの目次】

1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Stakeholders

2. Research Methodology
2.1 Research Data
2.1.1 Primary Data
2.1.2 Secondary Data
2.2 Market Size Estimation
2.3 Research Assumptions

3. Executive Summary

4. Industry Insights

5. Epigenetics Diagnostic market – By Product
5.1 Reagents
5.2 Kits
5.2.1 ChIP Sequencing Kit
5.2.2 Whole Genomic Amplification Kit
5.2.3 Bisulfite Conversion Kit
5.2.4 RNA Sequencing Kit
5.2.5 Others
5.3 Instruments
5.4 Enzymes
5.5 Services

6. Epigenetics Diagnostic market – By Technology
6.1 DNA Methylation
6.1.1 Reagents
6.1.2 Kits
6.1.3 Instruments
6.1.4 Enzymes
6.1.5 Services
6.2 Histone Methylation

6.2.1 Reagents
6.2.2 Kits
6.2.3 Instruments
6.2.4 Enzymes
6.2.5 Services
6.3 Histone Acetylation
6.3.1 Reagents
6.3.2 Kits
6.3.3 Instruments
6.3.4 Enzymes
6.3.5 Services
6.4 Large non-coding RNA
6.4.1 Reagents
6.4.2 Kits
6.4.3 Instruments
6.4.4 Enzymes
6.4.5 Services
6.5 MicroRNA Modification
6.5.1 Reagents
6.5.2 Kits
6.5.3 Instruments
6.5.4 Enzymes
6.5.5 Services
6.6 Chromatin structures

6.6.1 Reagents
6.6.2 Kits
6.6.3 Instruments
6.6.4 Enzymes
6.6.5 Services

7. Epigenetics Diagnostic, by Application
7.1 Oncology
7.1.1 Solid Tumours
7.1.2 Liquid Tumours
7.2 Non-oncology
7.2.1 Inflammatory Diseases
7.2.2 Metabolic Diseases
7.2.3 Infectious Diseases
7.2.4 Cardiovascular Diseases
7.2.5 Others

8. Epigenetics Diagnostic Market – By Region
8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 UK
8.2.4 Rest of Europe
8.3 Asia-Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Rest of APAC
8.4 LAMEA
8.4.1 Latin America
8.4.2 Middle East

9. Africa Competitive Landscape

10. Company Profiles
10.1 Alnylam Pharmaceuticals Inc.
10.2 Bavarian Nordic.
10.3 Cleveland BioLabs.
10.4 DynPort Vaccine Company LLC.
10.5 Elusys Therapeutics Inc.
10.6 Emergent BioSolutions Inc.
10.7 Ichor Medical Systems.
10.8 Ology Bioscience.
10.9 PharmAthene Inc.
10.10 SIGA Technologies Industries Ltd.
10.11 Other Players

11. Appendix

List of Tables
Table 1 Global Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 2 Global Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 3 Global Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 4 Global Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Region, (US$ Mn AGR%, CAGR%), 2019-2029
Table 5 North America Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 7 North America Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 8 North America Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 9 U.S. Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 10 U.S. Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 11 U.S. Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 12 Canada Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 13 Canada Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 14 Europe Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 15 Europe Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 16 Germany Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 17 France Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 18 UK Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 19 Rest of Europe Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 20 Rest of Europe Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 21 Asia-Pacific Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 22 Asia-Pacific Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 23 Japan Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 24 Japan Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 25 China Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 26 China Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 27 India Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR%), 2019-2029
Table 28 India Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 29 Rest of APAC Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 30 Rest of APAC Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 31 LAMEA Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 32 LAMEA Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 33 Latin America Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 34 Latin America Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 35 Middle East Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 36 Middle East Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2029
Table 37 Africa Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2029
Table 39 Africa Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2029
Table 40 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2030
Table 41Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2031
Table 42 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2032
Table 43 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2033
Table 44 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2034
Table 45 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2035
Table 46 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2036
Table 47 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2037
Table 48 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2038
Table 49 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2039
Table 50 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2040
Table 51 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2041
Table 52 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2042
Table 53 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2043
Table 54 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2044
Table 55 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Product, (US$ Mn AGR%, CAGR %), 2019-2045
Table 56 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Technology, (US$ Mn AGR%, CAGR %), 2019-2046
Table 57 Epigenetics Diagnostic Market Revenue Analysis & Forecast, By Application, (US$ Mn AGR%, CAGR %), 2019-2047

List of Figures
Figure 1 Global Pulmonary Arterial Hypertension Market: Segmentation
Figure 2 Global Pulmonary Arterial Hypertension Market: Research Design
Figure 3 Global Pulmonary Arterial Hypertension Market: Figure 3 Drivers, Restraints, Opportunities, and Challenges
Figure 4 Global Pulmonary Arterial Hypertension Market: By Product
Figure 5 Global Pulmonary Arterial Hypertension Market: By Technology
Figure 6 Global Pulmonary Arterial Hypertension Market: By Application
Figure 6 Global Pulmonary Arterial Hypertension Market: By Region
Figure 7 North America Pulmonary Arterial Hypertension Market: Market Snapshot
Figure 8 Europe Pulmonary Arterial Hypertension Market: Market Snapshot
Figure 9 Asia-Pacific Pulmonary Arterial Hypertension Market: Market Snapshot
Figure 10 LAMEA Pulmonary Arterial Hypertension Market: Market Snapshot
Figure 11 Celgene Corporation diagenode inc: Financial Snapshot
Figure 12 CellCentric Ltd.: Financial Snapshot
Figure 13 Chroma Therapeutics Ltd.: Financial Snapshot
Figure 14 Covaris Inc: Financial Snapshot
Figure 15 Diagenode Inc.: Financial Snapshot
Figure 16 Ribimed Biotechnologies: Financial Snapshot
Figure 17 Epigenomics AG: Financial Snapshot
Figure 18 Epitherapeutics: Financial Snapshot
Figure 19 Epizyme: Financial Snapshot
Figure 20 Karus Therapeutics: Financial Snapshot



★調査レポート[エピジェネティクス診断の世界市場2019-2029] ( Epigenetics Diagnostic Report 2019-2029 / VGN910353) 販売に関する免責事項
[エピジェネティクス診断の世界市場2019-2029] ( Epigenetics Diagnostic Report 2019-2029 / VGN910353) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆